Skip to main content
SpringerLink
Log in

Correction of biochemical and immunologic parameters in large bowel cancer by optimal doses of retinyl acetate and ascorbic acid

  • Oncology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literature Cited

  1. A. V. Sergeev, V. S. Anan'ev, et al., in: Proceedings of the 2nd Congress of Oncologists of the Belorussian SSR [in Russian], Minsk (1982), p. 96.

  2. N. N. Trapeznikov, V. I. Kupin, and Z. G. Kadagidze, in: The Clinical Use of Zymosan and a Study of the Mechanism of Its Action [in Russian], Riga (1982), p. 26.

  3. S. Sirisinha, M. D. Darip, and P. Moongkarndi, Clin. Exp. Immunol.,40, 125 (1980).

    Google Scholar 

  4. W. R. Thomas and P. G. Holt, Clin. Exp. Immunol.,32, 370 (1978).

    Google Scholar 

  5. H. J. Wanedo, R. Basker, F. Attiyeh, et al., Cancer (Philadelphia),45, 1254 (1980).

    Google Scholar 

Download references

Authors
  1. A. V. Sergeev
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sergeev, A.V. Correction of biochemical and immunologic parameters in large bowel cancer by optimal doses of retinyl acetate and ascorbic acid. Bull Exp Biol Med 96, 1298–1300 (1983). https://doi.org/10.1007/BF00834820

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00834820

Key Words

Search

Navigation